Suppression of splenic natural killer cell activity in rats with brain tumors

H Imaya1, H Matsuura, M Kudo

  • 1Department of Neurosurgery, Nippon Medical School, Tokyo, Japan.

Neurosurgery
|July 1, 1988
PubMed

Insights

Brain tumors in rats significantly reduced splenic natural killer (NK) cell activity. This immune suppression is linked to tumor-induced brain compression and potential neuroimmunomodulation.

Area of Science:

  • Neuroscience
  • Immunology
  • Oncology

Background:

  • Natural killer (NK) cells are crucial for immune surveillance.
  • The impact of brain tumors on peripheral immune organs like the spleen is not fully understood.

Purpose of the Study:

  • To investigate the effect of intracranial 9L glioma tumors on splenic NK cell activity in rats.
  • To explore the relationship between brain tumor progression, anatomical changes, and immune function.

Main Methods:

  • Inoculation of 9L glioma cells into rat brains or subcutaneous tissue.
  • Monitoring of splenic NK cell activity using a 51Cr release assay over 3 weeks.
  • Macroscopic and histological examination of spleens and brain structures.

Main Results:

  • Rats with brain tumors exhibited significantly decreased splenic NK cell activity compared to controls.
  • Spleens in tumor-bearing rats were morphologically small and atrophic.
  • Brain tumors caused compression of the basal ganglia, thalamus, and hypothalamus, leading to cerebral herniation and death.

Conclusions:

  • Intracranial gliomas suppress splenic NK cell activity in rats.
  • Neuroimmunomodulation, potentially mediated by hypothalamic dysfunction due to tumor compression, is a likely mechanism for this immune suppression.

Related Concept Videos